SMTL ID : 5dqf.1

Horse Serum Albumin (ESA) in complex with Cetirizine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

7 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.1: 5 residues within 4Å: Chain A: V.543, N.546, L.571, S.574, S.575 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.546 PG4.2: 8 residues within 4Å: Chain A: Y.146, K.195, L.234, H.238, R.253, A.257, S.283, A.287 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.253, A:S.283 PG4.3: 3 residues within 4Å: Chain A: L.390, E.393, K.541 1 PLIP interactions: 1 interactions with chain A Water bridges: A:E.393 PG4.4: 5 residues within 4Å: Chain A: V.420, E.421, R.424, K.428, I.519 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.424, A:K.428 PG4.5: 7 residues within 4Å: Chain A: L.63, F.67, G.244, D.245, L.246, L.247, E.248 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:L.246, A:L.247, A:E.248 PG4.6: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) PG4.7: 6 residues within 4Å: Chain A: C.261, E.262, H.263, Q.264, D.265, S.266 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.264, A:S.266

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.8: 4 residues within 4Å: Chain A: D.160, K.177, A.180, R.184 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.184 SO4.9: 4 residues within 4Å: Chain A: K.409, T.536, K.537, E.538 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.537 Salt bridges: A:K.409, A:K.537 SO4.10: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) SO4.11: 2 residues within 4Å: Chain A: K.496, K.530 5 PLIP interactions: 5 interactions with chain A Water bridges: A:T.416, A:T.416, A:K.496 Salt bridges: A:K.496, A:K.530

1 x LCR: (2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid(Non-covalent)

LCR.12: 10 residues within 4Å: Chain A: K.14, K.17, G.18, L.21, D.128, L.131, G.132, L.135, L.151, A.154 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:K.14, A:K.17, A:L.21, A:L.131, A:L.135 Salt bridges: A:D.128, A:D.128 Halogen bonds: A:L.151

1 x CZE: (2-{4-[(S)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid(Non-covalent)

CZE.13: 9 residues within 4Å: Chain A: R.205, A.209, D.320, L.323, G.324, L.327, L.343, K.347, E.350 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:R.205, A:A.209, A:A.209, A:L.327, A:L.343, A:K.347 Hydrogen bonds: A:R.205 Salt bridges: A:R.205, A:E.350, A:E.350 pi-Cation interactions: A:K.347

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.14: 6 residues within 4Å: Chain A: H.142, P.143, Y.144, F.145, S.189, R.193 Ligand excluded by PLIP CL.15: 2 residues within 4Å: Chain A: D.398, K.541 Ligand excluded by PLIP CL.16: 3 residues within 4Å: Chain A: G.203, E.204, R.205 Ligand excluded by PLIP CL.17: 2 residues within 4Å: Chain A: R.214, K.218 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Handing, K.B. et al., Crystal structure of equine serum albumin in complex with cetirizine reveals a novel drug binding site. Mol.Immunol. (2016)

Release Date

2015-12-23

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serum albumin